Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer
William C. Dooley(University of Oklahoma Health Sciences Center), Eileen B. King(Executive Office of the President), P Ganz(University of California, Los Angeles), U. Veronesi(Istituti di Ricovero e Cura a Carattere Scientifico), Deborah T. Hung(Massachusetts General Hospital), Marina Elena Cazzaniga(Azienda Ospedaliera San Gerardo), Joyce O’Shaughnessy(Baylor University Medical Center), David Euhus(The University of Texas Southwestern Medical Center), Bonnie L. King(Yale University), Benjamin O. Anderson(University of Washington), Bruce G. Haffty(Yale University), Laura J. Esserman(UCSF Helen Diller Family Comprehensive Cancer Center), Seema A. Khan(Northwestern University), Britt‐Marie Ljung(Executive Office of the President), Paul J. Schmit(University of California, Los Angeles), Henry M. Kuerer(The University of Texas MD Anderson Cancer Center), Susan L. Troyan(Harvard University Press), Jessica Quiring(Elabora Consultoria (Brazil)), Susan M. Love(University of California, Los Angeles), Mark C. Kelley(Vanderbilt University), David L. Page(Duke University), Rogsbert F. Phillips, Richard Elledge(Baylor College of Medicine), M. M. Anderson(Martin Luther King, Jr. Multi-Service Ambulatory Care Center), Raquel D Arias(University of Southern California), RD Clark(Breast Center), Fredric Kass
Cited by 275
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
|New England Journal of Medicine|1985|1.9k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
Definitions and guidelines for research on antibiotic persistence
|Nature Reviews Microbiology|2019|1.3k